Wednesday, June 10, 2026
🇺🇸 FDA

Patent directory · USPTO A61K / A61P

Patents matching “alzheimer”

52 pharma patents match "alzheimer" in our USPTO index (A61K/A61P) — applicant, grant date, expiration, and drug links.

Matches 52
Index total 30,257
Page 1 / 3

Quick answer

This filtered view shows 52 pharmaceutical patents matching "alzheimer" in our USPTO PatentsView index (CPC A61K/A61P). Search matches patent number, title, applicant, and CPC classification codes.

Patent results

52 results for “alzheimer” · 30,257 patents in full index Clear search

  1. WO 2026025082

    MÉTHODES DE TRAITEMENT DE LA MALADIE D'ALZHEIMER

    BIOGEN MA INC [US] · Granted Jan 29, 2026 · Expires Jan 24, 2046

    granted

  2. WO 2025184490

    N-[4-FLUOR-5-[[(2S,4R)-4-[(6-MÉTHOXY-4-PYRIMIDNYL)OXY]-2-MÉTHYL-1-PYRROLIDINYL]MÉTHYL]-2-THIAZOLYL]ACÉTAMIDE DESTINÉ À ÊTRE UTILISÉ DANS LE TRAITEMENT DE LA MALADIE D'ALZHEIMER

    BIOGEN MA INC [US] · Granted Sep 4, 2025 · Expires Aug 30, 2045

    granted

  3. US 12358892

    Metalloenzyme inhibitors for treating cancers, Alzheimer's disease, hemochromatosis, and other disorders

    Miralogx LLC · Granted Jul 15, 2025 · Expires Jul 10, 2045

    granted

  4. US 12329457

    Hyperspectral imaging for early detection of Alzheimer's disease

    Regents of the University of Minnesota · Granted Jun 17, 2025 · Expires Jun 12, 2045

    granted

  5. US 12280063

    Anti-retroviral therapies and reverse transcriptase inhibitors for treatment of Alzheimer's disease

    SANFORD BURNHAM PREBYS MEDICAL DISCOVERY INSTITUTE · Granted Apr 22, 2025 · Expires Apr 17, 2045

    granted

  6. WO 2025064824

    MÉTHODES DE TRAITEMENT DE LA MALADIE D'ALZHEIMER

    BIOGEN MA INC [US] · Granted Mar 27, 2025 · Expires Mar 22, 2045

    granted

  7. US 12241099

    Peptide therapeutics for treating Alzheimer's disease and related conditions

    The Board of Regents of the University of Oklahoma · Granted Mar 4, 2025 · Expires Feb 27, 2045

    granted

  8. US 12156879

    Combining BACE1 inhibitors with mGluR agonists for Alzheimer's disease therapy

    UNIVERSITY OF CONNECTICUT · Granted Dec 3, 2024 · Expires Nov 28, 2044

    granted

  9. US 12144815

    Use of aprepitant for treating Alzheimer's disease

    Hoth Therapeutics, Inc. · Granted Nov 19, 2024 · Expires Nov 14, 2044

    granted

  10. US 11819276

    Hyperspectral imaging for early detection of Alzheimer's disease

    Regents of the University of Minnesota · Granted Nov 21, 2023 · Expires Nov 16, 2043

    granted

  11. US 11679103

    Multi-targeting agents for Alzheimer's disease therapy

    The Regents of the University of California · Granted Jun 20, 2023 · Expires Jun 15, 2043

    granted

  12. US 11680062

    3,4-methylenedioxyphenylimidazolylethanonexime ether derivative, preparation method and use thereof, and drug for the treatment of Alzheimer's disease

    Northwest A & F University · Granted Jun 20, 2023 · Expires Jun 15, 2043

    granted

  13. US 11598774

    Methods of diagnosis and treatment of Alzheimer's Disease

    The Regents of the University of California · Granted Mar 7, 2023 · Expires Mar 2, 2043

    granted

  14. US 11571485

    Peptides and antibodies for detecting changes in alzheimer's disease brain and methods of use thereof

    SANFORD BURNHAM PREBYS MEDICAL DISCOVERY INSTITUTE · Granted Feb 7, 2023 · Expires Feb 2, 2043

    granted

  15. US 11549113

    Human alzheimer's disease and traumatic brain injury associated tau variants as biomarkers and methods of use thereof

    ARIZONA BOARD OF REGENTS FOR AND ON BEHALF OF ARIZONA STATE UNIVERSITY · Granted Jan 10, 2023 · Expires Jan 5, 2043

    granted

  16. US 11541086

    Compositions and methods for treating Alzheimer's disease

    Northwestern University · Granted Jan 3, 2023 · Expires Dec 29, 2042

    granted

  17. US 11503999

    Hyperspectral imaging for detection of Alzheimer's disease

    Regents of the University of Minnesota · Granted Nov 22, 2022 · Expires Nov 17, 2042

    granted

  18. US 11471449

    Use of pridopidine to improve cognitive function and for treating Alzheimer's disease

    The Board of Regents of the University of Texas System · Granted Oct 18, 2022 · Expires Oct 13, 2042

    granted

  19. US 11464768

    Pimavanserin alone or in combination for use in the treatment of Alzheimer's disease psychosis

    ACADIA Pharmaceuticals Inc. · Granted Oct 11, 2022 · Expires Oct 6, 2042

    granted

  20. US 11397188

    Method of detecting an APP Alzheimer's disease marker peptide in patients with Alzheimer's disease

    The Board of Regents of the University of Texas System · Granted Jul 26, 2022 · Expires Jul 21, 2042

    granted

  21. CA 3201259

    MASITINIB POUR LE TRAITEMENT DE LA MALADIE D'ALZHEIMER

    AB SCIENCE [FR] · Granted Jun 23, 2022 · Expires Jun 18, 2042

    granted

  22. US 11278529

    Methods for treating aggression associated with Alzheimer's disease

    OVID THERAPEUTICS INC. · Granted Mar 22, 2022 · Expires Mar 17, 2042

    granted

  23. US 11034739

    Ligand-guided phagocytosis based therapy for treatment of Alzheimer's disease and other neurodegenerative diseases

    The Board of Regents of the Nevada System of Higher Education on Behalf of the University of Nevada · Granted Jun 15, 2021 · Expires Jun 10, 2041

    granted

  24. US 10900041

    Antisense oligonucleotides for use in treating Alzheimer's disease

    ProQR Therapeutics II B.V. · Granted Jan 26, 2021 · Expires Jan 21, 2041

    granted

Drug approvals, clinical trials, M&A, event intelligence, and company updates — weekly.

Customize topics & region
Topics
Region

No spam. Unsubscribe anytime. See our privacy policy.